Company Information

  

Address: 11119 NORTH TORREY PINES ROAD
SUITE 200 
City: LA JOLLA 
State: CA 
Zip Code: 92037 
Telephone: 858-926-7655 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

The terms "we," "us," "our," "DarĂ©" or the "Company" refer collectively to DarĂ© Bioscience, Inc. and its wholly-owned subsidiaries, unless otherwise stated or the context otherwise requires. All information presented in this report is based on our fiscal year. Unless otherwise stated, references to particular years, quarters, months or periods refer to our fiscal years ending December 31 and the associated quarters, months and periods of those fiscal years. Overview We are a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's reproductive health. We are driven by a mission to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health and fertility.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/2018-4.17NAN/E
12/2017-3.56NAN/E
09/2017-14.66NAN/E
06/2017-88.90NAN/E
03/2017-115.00NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.45Total Liab/Total Assets0.07
Net Inc/Total Assets-0.81Total Liab/Inv Cap0.07
Net Inc/Inv Cap-0.87Total Liab/Comm Equity0.04
Pretax Inc/Net SalesNAInterest Coverage Ratio-34.65
Net Inc/Net SalesNACurr Debt/EquityNA
Cash Flow/Net SalesNALTD/EquityNA
SG&A/NetSalesNATotal Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio8.64
Inventory TurnoverNACurrent Ratio8.64
Inventory Day SalesNANet Rec/Curr Assets0.03
Net Sales/Work CapNAInv/Curr AssetsNA
Net Sales/PP&ENA  

Income Statement (Millions)

  3/31/2018 12/31/2017 6/30/2017 3/31/2017
Total Revenues(Net Sales) NA NA 1.83 NA
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 1.40 0.98 6.76 0.20
Operating Income -7.68 -9.14 -9.34 -0.23
Interest Exp NA 0.32 0.80 NA
Pretax Income -7.67 -9.13 -10.23 -0.24
Other Income 0.01 NA 1.41 -0.02
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -7.67 -9.13 -10.23 -0.24

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 6/30/2017 3/31/2017
Cash & Short Term Investments 15.63 7.56 7.24 12.03
Receivables - Total 0.03 0.28 0.89 1.14
Inventories - Total NA NA NA NA
Total Current Assets 15.94 8.35 8.13 15.61
Net Property, Plant & Equipment NA NA 0.02 0.11
Total Assets 16.63 14.26 8.15 15.95
Liabilities        
Accounts Payable 0.81 0.97 0.85 4.18
Debt in Current Liabilities NA 0.00 0.00 0.00
Total Current Liabilities 0.81 0.97 3.35 6.68
Long-Term Debt NA NA 0.00 0.00
Total Liabilities 0.81 0.97 4.09 8.21
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.00 0.00 0.00 0.00
Retained Earnings -19.90 -12.23 -211.15 -207.02
Treasury Stock NA NA NA NA
Total Stockholders' Equity 15.82 13.29 4.06 7.74
Total Liabilities and Stockholders' Equity 16.63 14.26 8.15 15.95

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 6/30/2017 3/31/2017
Net Cash Provided by Operating Activities -2.12 -0.96 -15.37 -0.05
Net Cash Provided by Investing Activities NA 0.00 2.12 NA
Net Cash Provided by Financing Activities 10.20 0.00 -14.51 0.10

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20130.01-17.14--
12/20140.08-23.34--
12/20150.00-39.59--
12/20160.00-0.67--
12/20170.00-11.50-3.56
Growth Rates-100.00----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/18191,0329.04




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.